Dissolution-rate enhancement of fenofibrate by adsorption onto silica using supercritical carbon dioxide.
Dissolution rate of a poorly water-soluble drug, fenofibrate, is increased by adsorbing the drug onto silica. The adsorption is achieved by first dissolving the drug in supercritical carbon dioxide and then depressurizing the solution onto silica. Loadings of up to 27.5 wt.% drug onto silica are obtained. Since solvents are not used in the loading process, the fenofibrate/silica formulation is free of any residual solvent, and carbon dioxide is freely removed upon depressurization. The formulation is characterized using infrared spectroscopy, ultraviolet spectroscopy, X-ray diffraction, differential scanning calorimetry and scanning electron microscopy. Based on in vitro dissolution study, a significant increase in the dissolution rate (approximately 80% drug release in 20 min) of drug-silica formulation is observed as compared to micronized fenofibrate (approximately 20% drug release in 20 min), which can be attributed to increase in the surface area and decrease in the crystallinity of drug after adsorption onto silica. Two different formulations are compared: (A) amorphous fenofibrate/silica and (B) slightly crystalline fenofibrate/silica. The second formulation is found to be more stable on storage.
Sanganwar
Ganesh P
GP
Department of Chemical Engineering, Auburn University, Auburn, AL 36849, USA.
Gupta
Ram B
RB
D002152:Calorimetry, Differential Scanning; D002245:Carbon Dioxide / Q000737:chemistry; D055598:Chemical Phenomena; D002626:Chemistry, Pharmaceutical; D002627:Chemistry, Physical; D025924:Chromatography, Supercritical Fluid; D004355:Drug Stability; D011345:Fenofibrate / Q000737:chemistry*; D006860:Hydrogen Bonding; D000960:Hypolipidemic Agents / Q000737:chemistry*; D007700:Kinetics; D008855:Microscopy, Electron, Scanning; D053758:Nanoparticles; D010316:Particle Size; D012822:Silicon Dioxide; D012995:Solubility; D013055:Spectrophotometry, Infrared; D017550:Spectroscopy, Fourier Transform Infrared; D014961:X-Ray Diffraction
D000960:Hypolipidemic Agents; D002245:Carbon Dioxide; D012822:Silicon Dioxide; D011345:Fenofibrate